OOIR: Observatory of International Research

Papers

(The TQCC of Modern Rheumatology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Comparison between the BioPlex 2200 ANA Screen™ and a conventional method with respect to the detection of autoantibodies	51
Correction to: Long-term safety and efficacy of belimumab in Japanese patients with SLE: A 7-year open-label continuation study	37
IL-18 receptor-α signalling pathway contributes to autoantibody-induced arthritis via neutrophil recruitment and mast cell activation	34
Consideration of useful patient-reported outcome measures to identify the unmet medical needs of children and adults with autoimmune and autoinflammatory diseases	34
Safety and effectiveness of sarilumab in Japanese patients with rheumatoid arthritis refractory to previous treatments: An interim analysis of a post-marketing surveillance	33
Management of patients with inflammatory rheumatic diseases after treatment failure with a first tumour necrosis factor inhibitor: A narrative review	33
The trends in the prevalence of arthritis and arthralgia and their associations with extra-articular manifestations in patients with Behcet’s disease: A systematic review and meta-analysis	32
Characteristics of patients presenting with concomitant carpal tunnel syndrome at the initial diagnosis with rheumatoid arthritis	29
1 mg/day or 10 mg/week? Folic acid supplementation with methotrexate in rheumatoid arthritis	29
The dietary acid load is associated with disease severity in psoriatic arthritis	28
Real-world safety and effectiveness of mepolizumab for patients with eosinophilic granulomatosis with polyangiitis in Japan: A 48-week interim analysis of the MARS study	24
The serum immunoglobulin G titres against Porphyromonas gingivalis as a predictor of clinical response to 1-year treatment with biological disease-modifying antirheumatic drugs in rheumatoid ar	24
Treatment outcomes of periprosthetic fracture following unlinked total elbow arthroplasty: A case series study	23
Safety and efficacy of switching immunosuppressive drugs for maintenance treatment in patients with systemic lupus erythematosus: A retrospective cohort study	22
The effectiveness and safety of subcutaneous methotrexate injection in Japanese patients with rheumatoid arthritis in a real-world setting	22
Assessing the efficacy of haemoperfusion for dermatomyositis-associated acute exacerbation of interstitial lung disease: A multicentre retrospective study	20
Correction to: Risk of hospitalized infections in older elderly patients with rheumatoid arthritis treated with tocilizumab or other biological/targeted synthetic disease-modifying antirheumatic drugs	20
Comparison of safety and effectiveness between etanercept biosimilar LBEC0101 and reference in patients with rheumatoid arthritis in real-world data using the KURAMA cohort	20
Age-related differences in the clinical phenotypes of Behçet’s disease: The experience of two referral centres	19
Rheumatoid factor value for determining the first biologic agent to use for non-systemic juvenile idiopathic arthritis	17
Development and validation of case-finding algorithms for identifying patients with systemic lupus erythematosus in an administrative claim database from tertiary care centers in Japan	17
Similarity and difference between systemic lupus erythematosus and NZB/W F1 mice by multi-omics analysis	17
Efficacy of anifrolumab in systemic lupus erythematosus patients with serological manifestations: A post hoc analysis of the Japan subgroup of the TULIP-2 trial	17
Disentangling temporal factors in organ damage accrual in systemic lupus erythematosus: Onset-age, onset-era, and ageing in the Japanese LUNA registry	16
Gut microbiota-immune axis in the regulation of rheumatoid arthritis: from mechanism to precision probiotic strategies	15

Early full weight-bearing and gait exercise after cemented total ankle arthroplasty with a modified anterolateral approach	15
Effectiveness and safety of tocilizumab, an anti–interleukin-6 receptor antibody, in 342 Japanese patients with multicentric Castleman disease: a 3-year, prospective, observational study	15
Illustrations of rheumatoid arthritis symptoms to promote communication between patients and physicians	15
Prevalence of social frailty in patients with rheumatoid arthritis: Data from a multicentre observational study (T-FLAG study)	14
Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-onset systemic sclerosis	13
Clinical implications of Vasculitis associated with familial Mediterranean fever: a comparative study in childhood	13
Association between the timing of intravenous immunoglobulin treatment and severity of Kawasaki disease	12
Can the affected intestinal segment visualized on abdominal ultrasound predict gastrointestinal tract bleeding in immunoglobulin A vasculitis?	12
Heating of the neck or elbows alleviates Raynaud’s phenomenon but has different effects on different types of patients with systemic sclerosis	11
Umbilical cord-derived mesenchymal stem cell therapy for knee osteoarthritis and cartilage repair: Current evidence and clinical applications	11
Evaluation of Ministry of Health, Labour and Welfare diagnostic criteria for antineutrophil cytoplasmic antibody–associated vasculitis compared to ACR/EULAR 2022 classification criteria	11
Predictors of the late recurrences of immunoglobulin A vasculitis due to clinical and laboratory features in children	11
Questionnaire survey on the prevention and development of cervical cancer in patients with systemic lupus erythematosus in Japan	10
Clinical characteristics of giant cell arteritis with ocular involvement: A single-centre retrospective study	10
VE-cadherin may suppress inflammation depending on the phase of inflammation of rheumatoid arthritis	10
Investigating the subchondral trabecular bone microstructure in patients with osteonecrosis of the femoral head using multi-detector row computed tomography	10
Effectiveness and safety of low-energy shock wave therapy for digital ulcers associated with systemic sclerosis: A Phase 3 pivotal clinical trial	10
Safety and effectiveness of ixekizumab in Japanese patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis in real-world use: a post-marketing safety study	10
Predictors of damage accrual in patients with antineutrophil cytoplasmic antibody–associated vasculitis: A nationwide prospective study	10
Diagnostic values and relevant factors of lumbar posterior lesions in axial spondyloarthritis	10
Reasons and risk factors for discontinuation of treatment with any biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: A long-term observational study	10
Subcutaneous administration of methotrexate in children with paediatric rheumatic diseases	10
Contribution of the factors to EuroQol 5 Dimensions in rheumatoid arthritis patients achieving low disease activity/remission with abatacept treatment: Post hoc subgroup analyses of the Japanes	10
Real-world efficacy, safety, and drug retention of anakinra and canakinumab in paediatric colchicine-resistant familial Mediterranean fever: Insights from a single-centre cohort	10
Impact of ongoing glucocorticoid use on postoperative complications following total knee arthroplasty: a Japanese nationwide propensity score–matched cohort study	10
Real-world treatment of gout and asymptomatic hyperuricaemia in Japan	9
Inflammation markers as risk factors for hypertension in primary Sjögren’s syndrome	9
Successful treatment of systemic lupus erythematosus with residual disease activity by switching from belimumab to anifrolumab	9
Prognostic nutritional index as an indicator for the development of bone fragility fracture in patients with rheumatoid arthritis	9
Validation of the 2019 EULAR/ACR classification criteria and clinical characteristics of childhood-onset Japanese patients with systemic lupus erythematosus	9
Associations of disease duration and anti-citrullinated peptide antibody status with the effectiveness of abatacept in biologic-naïve patients with rheumatoid arthritis: Post hoc analysis of a	9
Analysis of the saliva microbiome in patients with immunoglobulin G4–related disease	9
Validation of the MCK model for predicting outcomes in myopathy-associated interstitial lung disease: a multicentre MYKO cohort study	9
Three-year safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Final analysis of an all-case postmarketing surveillance study	9
Pearls and pitfalls in imaging of axial spondyloarthritis for rheumatologists	9
High plasma homocysteine level is associated with increased prevalence of the non-remission state in rheumatoid arthritis: Findings from the KURAMA cohort	9
Assessment of muscle quality and quantity in individuals with diffuse idiopathic skeletal hyperostosis	9
Impact of anti-drug antibodies and neutralising antibodies on safety and efficacy of ozoralizumab in rheumatoid arthritis	9
Comparison of effectiveness of methotrexate in patients with late-onset versus younger-onset rheumatoid arthritis: Real-world data from an inception cohort in Japan (NICER-J)	9
Structural, nonclinical, and clinical features of ozoralizumab: A novel tumour necrosis factor inhibitor	8
Mortality and risk factors in Japanese patients with rheumatoid arthritis: a 14-year observation of the IORRA cohort	8
Characteristics of patients with polymyalgia rheumatica based on glucocorticoid dose in Japan: A cohort study using routinely collected health data	8
Can baseline features predict progression to defined connective tissue disease? Insights from a minimum 5-year follow-up study of 504 patients with undifferentiated connective tissue disease: A retros	8
Significant association of HLA-A26 with uveitis and gastrointestinal involvement in patients with Behçet’s disease in a multicentre study	8
Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naïve to MTX treatment (FINCH 3)	8
Safety and effectiveness of peficitinib 100 mg/day in patients achieving clinical remission from a long-term open-label extension study in Japan, Korea, and Taiwan (RAJ2)	8
Efficacy and safety of febuxostat in Japanese paediatric patients with hyperuricaemia including gout: Phase 2, single arm, open‒label, multicentre studies	8
Association between pan-immune-inflammation value and mortality in osteoarthritis: evidence for elevated risk at higher levels	8
Exploring brain metabolism and cognitive impairment in childhood-onset systemic lupus using fluorodeoxyglucose positron emission tomography	8
Response to Dr Urata’s Letter to the Editor of Modern Rheumatology regarding a study of “Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders”	8

Non-B27 HLA-B alleles lack diagnostic value, necessitating composite clinical indices to distinguish axial spondyloarthritis from radiographic mimics in Japanese patients	8
Drug-survival profiling of second-line biologic therapy in rheumatoid arthritis: Choice of another tumour necrosis factor inhibitor or a biologic of different mode of action?	8
Rheumatoid arthritis at a turning point in the era of targeted therapies	7
Laboratory markers predicting tofacitinib efficacy in Japanese patients with rheumatoid arthritis: A pooled analysis of Phase 2/3 randomised controlled clinical trials	7
Association of bisphosphonate with bone loss and pain-related behaviour in an adjuvant-induced osteoporosis model	7
Elucidation of factors influencing spinal ankylosis in patients with axial spondyloarthritis	7
Predictors of disease course in systemic juvenile idiopathic arthritis	7
Non-infectious uveitis referred for pediatric rheumatologic assessment and management: A Portuguese retrospective study	7
Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: A retrospective, multi-center descriptive study: Comment on the article by Na	7
Efficacy and safety of anakinra for acute calcium pyrophosphate deposition disease flare: a systematic review and meta-analysis	7
Feasibility and applicability of locomotive syndrome risk test in elderly patients who underwent total knee arthroplasty	7
Telemedicine for paediatric rheumatic diseases in Japan: a national survey of physicians’ perspectives	7
Comprehensive assessment of patients with symptomatic hand osteoarthritis: Cross-sectional insights into links with other joints	7
Prevalence of and factors associated with radiographic sacroiliitis in Japanese patients with inflammatory bowel disease: A computed tomography–based study	7
Prevalence of high and low serum alkaline phosphatase levels and the associated factors in patients with rheumatoid arthritis: Results from the IORRA cohort study	7
The relationship between locomotive syndrome and depression in young Chinese college students	7
Evaluation of articular cartilage degeneration in patients with osteonecrosis of the femoral head using T2 mapping magnetic resonance imaging	6
Severity scores, damage indices, and the concept of the colchicine-resistant patient in familial Mediterranean fever	6
Impact of deep remission on renal flare in pure class V lupus nephritis: results from KEIO-SLE cohort, a retrospective cohort study	6
Assessment of the dorsal tangent of the metacarpal neck as an intraoperative reference for metacarpophalangeal joint arthroplasty	6
Gender differences in patient experience in idiopathic inflammatory myopathies: Subanalysis from the COVAD dataset	6
Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: Long-term efficacy and safety	6
Severe COVID-19 in patients with immune-mediated rheumatic diseases: A stratified analysis from the SORCOM multicentre registry	6
Factors associated with osteoporosis and fractures in patients with systemic lupus erythematosus: Kyoto Lupus Cohort	6
A clinical overview of paediatric sarcoidosis: Multicentre experience from Turkey	6
Radiographic study of the distal ulna in rheumatoid arthritis with extensor digitorum communis ruptures	6
Risk of 90-day readmission for heart failure among patients with rheumatoid arthritis: A retrospective cohort study	6
A narrative review of the diagnostic role of muscle biopsy in small- to medium-vessel vasculitis: Consideration of imaging-guided procedures	6
Verification of unmet medical needs in patients with juvenile idiopathic arthritis in Japan	6
Nervous system involvement in primary Sjögren’s syndrome: analysis from the Sjögrenser registry	6
Prognostic factors affecting respiratory-related death in patients with rheumatoid arthritis complicated by interstitial lung disease: An ANSWER cohort study	6
Elevated serum heparin-binding protein levels in patients with gout flare	6
Polypharmacy prevalence and associated factors in patients with systemic lupus erythematosus: A single-centre, cross-sectional study	6
Prevalence, patient characteristics and treatment patterns among systemic lupus erythematosus–pulmonary arterial hypertension patients in real-world clinical practice: A retrospective analysis of Medi	6
Nation wide cohort study of Japanese patients with ANCA associated vasculitis using rituximab Effectiveness and safety after two years	5
Mid- to long-term outcomes of high tibial osteotomy in patients with rheumatoid arthritis	5
Grip strength asymmetry as a better indicator of residual hand symptoms than absolute grip strength after achieving treat-to-target in rheumatoid arthritis	5
Differences in sex- and age-associated mortality in patients with anti-MDA5-positive dermatomyositis	5
Romosozumab increases bone mineral density in Japanese older adults with osteoporosis	5
A multicentre, large-scale, observational study of tocilizumab in patients with giant cell arteritis in Japan	5
Multicentre development and validation of data-driven claims-based algorithms for identifying dermatomyositis and polymyositis in Japan	5
Correction to: Anti-arthritic effects of polyunsaturated fatty acid–rich supplementation combined with selective soluble epoxide hydrolase inhibitors in a collagen-induced arthritis mouse model	5
Relationship between the phase angle from bioelectrical impedance analysis and daily physical activity in patients with rheumatoid arthritis	5
Prospective follow-up of patients with probable Behçet’s disease: first results of an inception cohort	5
A multicentre, prospective registry of patients with systemic sclerosis in Japan: baseline patient characteristics	5
Exploratory comparison of diffusion-weighted whole-body imaging with background body signal suppression and 18F-FDG PET/CT for assessing disease activity in large-vessel vasculitis	5
Evaluation of 334 paediatric chronic non-bacterial osteomyelitis cases: A multicentre cohort study defining clusters	5
Risk factor analysis of vertebral fractures requiring surgery in patients with ankylosing spondylitis	5
Risk factors for cytomegalovirus reactivation during the treatment of ANCA-associated vasculitis: A retrospective cohort study of the J-CANVAS study	5
Cardiac magnetic resonance imaging analysis of cardiac involvement in eosinophilic granulomatosis with polyangiitis	5
Frozen shoulder. An overview of pathology and biology with hopes to novel drug therapies	5
Challenges nurses face in providing care for patients with juvenile idiopathic arthritis	5
PREDICT-crFMF score: A novel model for predicting colchicine resistance in children with familial Mediterranean fever	5
Cut-off values for achieving osteoporosis treatment goals in women with rheumatoid arthritis receiving denosumab	5
Association of spinal ankylosis with spinal mobility and functional impairment in radiographic axial spondyloarthritis: A computed tomography study	5
Intervertebral fusion sites in patients with ankylosing spondylitis: A computed tomography study	5
Association of denosumab with serum cytokines, chemokines, and bone-related factors in patients with rheumatoid arthritis: A post hoc analysis of a multicentre, open-label, randomised, parallel	5